8,954
Total Claims
$696K
Drug Cost
852
Beneficiaries
$817
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-42%
Cost per patient vs peers
$817 vs $1,411 avg
-28%
Brand preference vs peers
7.7% vs 10.6% avg
Brand vs Generic
92% generic
Brand: 678 claims · $495K
Generic: 8,173 claims · $196K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phosphate | 78 | $87K |
| Insulin Glargine,hum.Rec.Anlog | 101 | $61K |
| Empagliflozin | 52 | $59K |
| Apixaban | 62 | $57K |
| Dapagliflozin Propanediol | 27 | $30K |
| Semaglutide | 19 | $25K |
| Atorvastatin Calcium | 903 | $23K |
| Losartan Potassium | 489 | $15K |
| Metformin Hcl | 746 | $14K |
| Insulin Glargine,hum.Rec.Anlog | 19 | $13K |
| Ipratropium/Albuterol Sulfate | 29 | $13K |
| Enalapril Maleate | 254 | $8,502 |
| Diclofenac Sodium | 212 | $7,968 |
| Levothyroxine Sodium | 266 | $6,483 |
| Tamsulosin Hcl | 245 | $6,481 |
Prescribing Profile
Patient Profile
72
Avg Age
49%
Female
1.18
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data